These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12182966)

  • 1. Cardiovascular effects of cannabinoids.
    Randall MD; Harris D; Kendall DA; Ralevic V
    Pharmacol Ther; 2002 Aug; 95(2):191-202. PubMed ID: 12182966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexities of the cardiovascular actions of cannabinoids.
    Randall MD; Kendall DA; O'Sullivan S
    Br J Pharmacol; 2004 May; 142(1):20-6. PubMed ID: 15131000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quest for a vascular endothelial cannabinoid receptor.
    Kunos G; Bátkai S; Offertáler L; Mo F; Liu J; Karcher J; Harvey-White J
    Chem Phys Lipids; 2002 Dec; 121(1-2):45-56. PubMed ID: 12505689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.
    Ralevic V; Kendall DA; Randall MD; Smart D
    Life Sci; 2002 Oct; 71(22):2577-94. PubMed ID: 12354577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids: a new class of vasoactive substances.
    Randall MD; Kendall DA
    Trends Pharmacol Sci; 1998 Feb; 19(2):55-8. PubMed ID: 9550942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
    Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.
    Navarro M; Rodríguez de Fonseca F
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):379-85. PubMed ID: 9974172
    [No Abstract]   [Full Text] [Related]  

  • 8. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid system as a target for therapeutic drugs.
    Piomelli D; Giuffrida A; Calignano A; Rodríguez de Fonseca F
    Trends Pharmacol Sci; 2000 Jun; 21(6):218-24. PubMed ID: 10838609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids: new targets for drug development.
    Di Marzo ; Bisogno T; De Petrocellis L
    Curr Pharm Des; 2000 Sep; 6(13):1361-80. PubMed ID: 10903398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of endocannabinoids--the plot thickens.
    Kunos G; Járai Z; Varga K; Liu J; Wang L; Wagner JA
    Prostaglandins Other Lipid Mediat; 2000 Apr; 61(1-2):71-84. PubMed ID: 10785543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
    Malinowska B; Kwolek G; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery.
    Randall MD; Kendall DA
    Eur J Pharmacol; 1998 Apr; 346(1):51-3. PubMed ID: 9617751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids as cardiovascular modulators.
    Kunos G; Járai Z; Bátkai S; Goparaju SK; Ishac EJ; Liu J; Wang L; Wagner JA
    Chem Phys Lipids; 2000 Nov; 108(1-2):159-68. PubMed ID: 11106789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and the gut.
    Pinto L; Capasso R; Di Carlo G; Izzo AA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):333-41. PubMed ID: 12052047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
    Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
    Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cannabinoids: metabolism and their role in reproduction.
    Habayeb OM; Bell SC; Konje JC
    Life Sci; 2002 Mar; 70(17):1963-77. PubMed ID: 12148689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA; Járai Z; Bátkai S; Kunos G
    Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.
    Hiley CR; Ford WR
    Biol Rev Camb Philos Soc; 2004 Feb; 79(1):187-205. PubMed ID: 15005177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.